Skip to main content
LLY
NYSE Life Sciences

Lilly's Retatrutide Shows Up to 28.3% Weight Loss in Phase 3 Trials, Reinforcing GLP-1 Dominance

Tom Rudovsky · Reported by Wiseek News
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment info
Positive
Importance info
9
Price
$1,064.59
Mkt Cap
$1.003T
52W Low
$623.78
52W High
$1,133.95
52W Position info
71% above low
Off High info
6.1% below high
Rel. Volume info
1.1× avg
Market data snapshot near publication time

LLY sits 71% above its 52-week low of $623.78.

Summary

Eli Lilly's investigational drug Retatrutide achieved significant weight loss of up to 28.3% (70.3 lbs) over 80 weeks in Phase 3 trials, with approximately 45% of participants achieving at least 30% weight loss. This strong clinical data for another key pipeline asset further solidifies Lilly's leading position in the rapidly growing GLP-1 and weight loss treatment market, following recent FDA approval for Foundayo. The results indicate a highly competitive profile for Retatrutide, reinforcing the company's long-term growth prospects.

At the time of this announcement, LLY was trading at $1,064.59 on NYSE in the Life Sciences sector, with a market capitalization of approximately $1T. The 52-week trading range was $623.78 to $1,133.95. This news item was assessed with positive market sentiment and an importance score of 9 out of 10. Source: Wiseek News.


Price Chart

Share this article

Copied!

LLY - Latest Insights

LLY
Nov 04, 2026, 1:53 AM EST
Source: Reuters
Importance Score:
7
Price at Filing: $1,416.54
Real-time Price: $1,366.76 info
Change: -$49.78 (-4%) info
Market Cap: $1.284T info
LLY
Oct 29, 2026, 3:21 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $1,368.10
Real-time Price: $1,366.76 info
Change: -$1.34 (-0.10%) info
Market Cap: $1.284T info
LLY
Oct 29, 2026, 12:08 PM EDT
Source: Dow Jones Newswires
Importance Score:
9
Price at Filing: $1,370.30
Real-time Price: $1,366.76 info
Change: -$3.54 (-0.26%) info
Market Cap: $1.284T info
LLY
Oct 29, 2026, 11:35 AM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $1,363.50
Real-time Price: $1,366.76 info
Change: +$3.26 (+0.24%) info
Market Cap: $1.284T info
LLY
Oct 29, 2026, 7:03 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1,344.00
Real-time Price: $1,366.76 info
Change: +$22.76 (+2%) info
Market Cap: $1.284T info